References
- K. D. Tripathi, Essentials of Medicinal Pharmacology, 3rd ed., New Delhi 1995, p. 737.
- British Pharmacopoeia, Her Majesty's Stationery Office, Vol. I, London 2001, pp. 1253-1254.
- European Pharmacopoeia, 5th ed., European Directorate for the Quality of Medicines, Council of Europe, Strasbourg 2004, p. 2194.
- D. Mundle and S. G. Kashedikar, Spectrophotometric estimation of pefloxacin mesylate in pharmaceutical formulations, Indian Drugs33 (1996) 407-408.
- X. Qin, Ultra-violet spectrophotometric determination of content of pefloxacin mesylate preparations, Yaowu Fenxi Zazhi14 (1994) 61-62; ref. Anal. Abstr. 56 (1994) 7G50.
- A. K. S. Ahmad, M. A. Kawy and M. Nebsen, Spectrophotometric and spectrofluorimetric determination of pefloxacin, Anal. Lett.30 (1997) 809-820.
- H. Salem, Spectrofluorimetric, atomic absorption spectrometric and spectrophotometric determination of some fluoroquinolones, Am. J. Appl. Sci.2 (2005) 719-729.
- C. Fierens, S. Hillaert and W. Van den Bossche, The qualitative and quantitative determination of quinolones of first and second generation by capillary electrophoresis, J. Pharm. Biomed. Anal.22 (2000) 763-772.
- Y. Chen, Y. G. Li, J. G. Ge, F. M. Han and Z. B. Yuan, Polarographic study of pefloxacin mesylate and its analytical applications, Fenxi Shiyanshi15 (1996) 76-78; ref. Anal. Abstr.59 (1997) 2G36.
- N. Abanmi, I. Zaghloul, N. El-Sayed and K. I. Al-Khamis, Determination of pefloxacin and its main active metabolite in human serum by high-performance liquid chromatography, Ther. Drug Monitor.18 (1996) 158-163.
- G. Carlucci, G. Palumbo and P. Mazzeo, Simple and rapid analysis of pefloxacin, fenbufen and felbinac in human plasma using high performance liquid chromatography, J. Liq. Chromatogr. Relat. Technol.19 (1996) 1107-1115.
- S. S. Deng and R. Q. Xu, HPLC determination of pefloxacin mesylate in serum, Yaowu Fenxi Zazhi15 (1995) 37-38; ref. Anal. Abstr.57 (1995) 12G65.
- A. P. Argekar, S. V. Kapadia, S. V. Raj and S. S. Kunjir, Quantitative determination of lomefloxacin, ofloxacin, pefloxacin and enrofloxacin by RP-HPLC, Indian Drugs33 (1996) 261-266.
- I.-P. Chen, C.-Y. Shaw and B.-L. Chang, Simultaneous determination of six quinolone antibacterial agents by HPLC, Yaowu Shipin Fenxi4 (1996) 155-164; ref. Anal. Abstr.59 (1997) 1G39.
- K. Basavaiah and H. C. Prameela, Quantitative determination of pefloxacin mesylate by residual- base neutralization method, J. Serb. Chem. Soc.69 (2004) 403-410.
- K. Basavaiah and H. C. Prameela, Sensitive spectrophotometric method for the determination of pefloxacin, Indian J. Chem. Technol.9 (2002) 428-431.
- B. S. Kuchekar and R. S. Shetty, Spectrophotometric determination of pefloxacin in dosage forms, J. Inst. Chem. (India)65 (1993) 185.
- A. B. Avadhanulu and A. R. R. Pantulu, Spectrophotometric determination of pefloxacin in its dosage forms, Indian Drugs31 (1994) 258-262.
- M. N. Reddy, M. Swapna, K. V. K. Rao and D. G. Sankar, Spectrophotometric determination of pefloxacin, Indian Drugs35 (1998) 105-106.
- M. Jelikic-Stankov, D. Veselinovic, D. Melesev and Z. Radovic, Spectrophotometric determination of pefloxacin in pharmaceutical preparations, J. Pharm. Biomed. Anal.7 (1989) 1571-1577.
- S. Mostafa, M. El-Sadek and E. A. Alla, Spectrophotometric determination of ciprofloxacin and pefloxacin through charge transfer complexation, J. Pharm. Biomed. Anal.27 (2002) 133-142.
- H. Salem, Colorimetric and atomic absorption spectrometric determination of some fluoroquinolone derivatives, Sci. Pharma.72 (2004) 51-71.
- S. Mostafa, M. El-Sadek and E. A. Alla, Spectrophotometric determination of enrofloxacin and pefloxacin through ion-pair complex formation, J. Pharm. Biomed. Anal.28 (2002) 173-180.
- R. T. Sane, V. Dighe, V. V. Bapat and M. G. Gangrade, Extractive colorimetric method for the determination of pefloxacin mesylate dihydrate from pharmaceutical preparations, Indian J. Pharm. Sci.53 (1991) 64-66.
- ICH Harmonised Tripartite Guideline, prepared within the International Conference on the Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH), ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2 (R1), CPMP/ICH, London 1995